A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 01 04 2019
accepted: 07 11 2019
pubmed: 8 12 2019
medline: 11 8 2020
entrez: 8 12 2019
Statut: ppublish

Résumé

Computationally optimized broadly reactive Ags (COBRA) targeting H1 elicit a broad cross-reactive and cross-neutralizing Ab response against multiple H1N1 viral strains. To assess B cell breadth,

Identifiants

pubmed: 31811019
pii: jimmunol.1900379
doi: 10.4049/jimmunol.1900379
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Viral 0
Broadly Neutralizing Antibodies 0
Epitopes, B-Lymphocyte 0
H1N1 virus hemagglutinin 0
Hemagglutinin Glycoproteins, Influenza Virus 0
Influenza Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

375-385

Informations de copyright

Copyright © 2020 by The American Association of Immunologists, Inc.

Auteurs

Giuseppe A Sautto (GA)

Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.

Greg A Kirchenbaum (GA)

Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.

Rodrigo B Abreu (RB)

Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.

Jeffrey W Ecker (JW)

Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.

Spencer R Pierce (SR)

Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602.

Harry Kleanthous (H)

Sanofi Pasteur, Cambridge, MA 02139; and.

Ted M Ross (TM)

Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602; tedross@uga.edu.
Department of Infectious Diseases, University of Georgia, Athens, GA 30602.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH